Found 90 matching trials
Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer PHASE2 This pilot phase IIb trial studies how well pembrolizumab and CXCR4 antagon...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors PHASE2 The primary objective of the study is to estimate the antitumor efficacy of...
Show More Location
Innovative Clinical Research Institute
Learn More & Join Trial
A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) PHASE1 The goal of this study is to learn about the safety of different doses of M...
Show More Location
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301)
Learn More & Join Trial
A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma PHASE2 This is an open-label clinical study designed to evaluate the efficacy of S...
Show More Location
Multiple Locations
Learn More & Join Trial
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors PHASE1 This phase I trial studies the side effects and best dose of pembrolizumab ...
Show More Status
Active Not Recruiting
Location
University of California Davis Comprehensive Cancer Center
Learn More & Join Trial
Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial studies how well giving pembrolizumab with s...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
TEIPP Immunotherapy in Patients With NSCLC PHASE1 In this multicenter, open label non-randomized phase I/II dose escalation s...
Show More Location
Leiden University Medical Center
Learn More & Join Trial
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease PHASE3 The primary objective of this study is to evaluate the effectiveness of zan...
Show More Location
Multiple Locations
Learn More & Join Trial
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC PHASE2 A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy o...
Show More Learn More & Join Trial